A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Cassava Sciences Inc stock. As of the latest transaction made, Renaissance Technologies LLC holds 81,100 shares of SAVA stock, worth $310,613. This represents 0.0% of its overall portfolio holdings.

Number of Shares
81,100
Holding current value
$310,613
% of portfolio
0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$9.57 - $35.08 $776,127 - $2.84 Million
81,100 New
81,100 $2.39 Million
Q4 2020

Feb 10, 2021

SELL
$6.79 - $12.25 $762,517 - $1.38 Million
-112,300 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$2.86 - $11.51 $321,178 - $1.29 Million
112,300 New
112,300 $1.29 Million
Q2 2020

Aug 13, 2020

SELL
$2.04 - $9.64 $1.33 Million - $6.3 Million
-653,759 Closed
0 $0
Q1 2020

May 14, 2020

SELL
$3.26 - $9.65 $1.18 Million - $3.49 Million
-362,000 Reduced 35.64%
653,759 $2.69 Million
Q4 2019

Feb 13, 2020

BUY
$1.1 - $6.12 $180,181 - $1 Million
163,801 Added 19.23%
1,015,759 $5.28 Million
Q3 2019

Nov 13, 2019

BUY
$1.04 - $1.45 $175,932 - $245,290
169,166 Added 24.78%
851,958 $1.02 Million
Q2 2019

Aug 12, 2019

BUY
$1.02 - $1.34 $100,878 - $132,526
98,900 Added 16.94%
682,792 $826,000
Q1 2019

May 14, 2019

BUY
$0.92 - $1.29 $537,180 - $753,220
583,892 New
583,892 $753,000

Others Institutions Holding SAVA

About CASSAVA SCIENCES INC


  • Ticker SAVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,097,900
  • Market Cap $154M
  • Description
  • Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...
More about SAVA
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.